chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hospitalized 10/18/2021; COVID-19 positive 10/17/2021; fully vaccinated    BRIEF OVERVIEW: Discharge Provider:  DO  Primary Care Provider at Discharge: DO Admission Date: 10/18/2021 Discharge Date: 10/20/2021 Discharge disposition: Home Condition on discharge: Stable DETAILS OF HOSPITAL STAY:   Hypoxia [R09.02]   HOSPITAL COURSE:   Acute on chronic respiratory failure with hypoxia. Resolved. Back on baseline O2 needs of 6L  COVID19 infection. Improving  ILD -presents w/ 1 month of progressive dyspnea w/ 2 days of more acute worsening -in ED was saturating well on FIO2 of 50% from BL 6L NC -CT angio thorax shows no acute process -is vaccinated -wife is getting over COVID19 -wean off oxygen as able.  Patient nearing his baseline -Remdesivir, steroids, SQ lovenox per COVID19 treatment with improvement.  -To finish Decadron course at home. Lovenox at home  -pulmonary evaluated  Chronic systolic heart failure s/p AICD -EF 35% -appears euvolemic -continue home meds -CHF diet, daily weights, I/Os No ACEi or Spironolactone Rx due to soft BP and currently recovery from COVID 19. To be considered later on by his cardiologist. Also pt considering hospice due to new diagnosis of gastric adenocarcinoma and chronic illness, so may not be indicated  Hospice note 10/21/2021: Reason for referral:  10/21/21: I spoke with patient's spouse by phone, she was tearful regarding his declines. He was seen by hospital team yesterday and at that time did not feel that they were ready for hospice care, he wanted time to recover from Covid before making a decision (patient is currently Covid positive). He was discharged from the hospital yesterday with a referral for home care. Wife then called this morning stating that he has been up most of the night with shortness of breath., on 15L NC, Medical equipment store is bringing a second concentrator this morning as he only had one that went to 10L and was then using a supplemental tank which they used up last night. Nurse did info visit in hospital and started the discussion on morphine for SOB symptoms, they were hesitant on this at first but after last night, he states he is willing to try to get some relief. Patient passed away on 10/22/2021 per hospice note
It was discovered after the vaccine was administered that it was not properly diluted. Parents were notified. They stated their child was in school and did not have any symptoms of a reaction. Requested they monitor their child and report any issues to us.
A few months after receiving my vaccine I had to use a can to walk around because I was having leg pain. As well as heel pain. I thought ti was a bone spur. I used a cane to alleviate some of the pressure. Around August 31st is when I noticed my symptoms. I was walking down 5 flights of stairs and I was fine, and as we got closer to the car I was having trouble catching my breath. The car was 3 blocks away and I could not make it it without stopping. We had to stop at a bus stop so I could stop and sit down. I thought I might be having an asthma attack so we hooped on the bus and went to the pharmacy to get pick up an inhaler since I did not have mine on me. It did not help me out at all. We went home. A few days later September 4th we went to visit my daughters friend in the hospital , and I was having issues again and my daughter said she thought I was having heart issues and she made me go to ER. I went to the ER because I thought I was having an asthma attack. They did not think that was the case because I was not wheezing. They drew blood and found it I may have a blood clot. X-rays, CAT SCAN legs and chest. Then they put me in the ICU in the ER because they found blood clots in my legs and chest. They admitted  me September 5th to the hospital in the step down unit from ICU. I was in the hospital until September 16th. While in the hospital they started you Eloquist but took me off because there is not enough studies down for women of my size. So they switched me to  Heparin and Warfarin. After 3 days they moved me to regular unit and took me off of Lorsartan because my blood pressure returned to normal. Heparin was increased a few times. I am still being monitored being closely.
First time he took it (2/15/17) - systemic itching; Second time (2/17/17) developed a macropapular rash on back.
Sudden onset of dizziness. B/P 171/98- O2 sat on room air. Glucose normal at 162. B/P came in low in the ER. Sent home. Had fever overnight. Reports she felt ok the following day.
pt died 28MAR99;pt recv vax30AR99;no other adverse reactions were reported;found in crib apneic & pulseless;taken to hosp & tried to be resuscitated but unsuccessful;
fever to 105 degrees, chills, muscle pain, nausea, vomiting. Took 1000mg Tylenol.  Within 6 hours symptoms. were gone.  States he felt good the next day, and back to work fine the following day.
Hey so here's the facts.   My 6yo daughter was given first dose of Hep B on a Thursday 12-5   Friday night 12-6 she developed bad asthma cough, Saturday morning coughing a lot. Saturday night she comes down with fever. Sunday 12-8  we head to hospital for asthma treatment. Then sent home. Monday coughing up and vomiting of phlegm. Wednesday 12-11 we see Doctor. Dr says nothing to do with vaccine. doesn't want to file a report. She is given Antibiotics for possible lung infection... pnuemonia.  Two weeks after vaccine, her lungs are clear..shes been well. Then she has ear pains for the First time morning of 12-23 Doctors prescribe Antibiotics for possible ear infection.
SORE BODY; WOKE UP WITH CHILLS; FEVER KICKED AGAIN; PRETTY TIRED; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced sore body, woke up with chills, fever kicked again, and pretty tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever kicked again, woke up with chills, sore body, and pretty tired. This report was non-serious.
Fever 101.5 for four days so far,  malaise , restlessness, headache, back pains, abdominal pains, shivering ,  ibuprofen lowers but not completely
This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 01-SEP-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 with lot # L007720 Expiration date: 08-JUL-2018, 0.5 ml (route and anatomical location of administration were not reported). The sum of hours in excursion was 8 hours and the lowest recorded temperature reported was 34 Fahrenheit (F) (1.111111111 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor Product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Patient reports last week he had elevated temperature, headache, malaise, and decreased appetite. On 24 January 2014, the patients girlfriend noted small bumps over his back and anterior collar bone area that do not itch. Patient reports the small bumps on his lower legs and ankles do itch.
Strawberry red bumpy rash head to toe, fever, Ibuprofen (children). Baking soda.
feeling sick with flu symptoms; second dose not received in allowed time window; This spontaneous case was reported by a non-health professional and describes the occurrence of MALAISE (feeling sick with flu symptoms) and PRODUCT DOSE OMISSION ISSUE (second dose not received in allowed time window) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (feeling sick with flu symptoms) and PRODUCT DOSE OMISSION ISSUE (second dose not received in allowed time window). At the time of the report, MALAISE (feeling sick with flu symptoms) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (second dose not received in allowed time window) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication provided by reporter. No concomitant medication provided by reporter. No lab data history provided by reporter   Reporter did not allow further contact
Pt states that left thigh (within 1/2hr of injections) developed huge dark, red mark, the size of 2 quarters over the area of the injection give closer to the knee. Redness was gone by 04/14/2002 but tender to touch, huge lump (size of nickle) at the site, and temp 100.1 deg. F.
Fri 6/25/10 mother noticed redness and swelling of LT splotchy and red.  Approx 3 inches diameter warm to touch.  Sat 6/26/10 L leg fiery red and hot to touch approx 4 inches in diameter.  Parent applied warm compress.  Sat. 6/26/10 PM - took child to ER.  Child treated with BENADRYL.  PREDNISONE and KEFLEX.
Within 12 hrs of getting the booster i had fever as high as 102.3. Body aches. Chills. Headache. Vomiting. Diarrhea. Disorented. Extremely tired.  Lasted for 3days. On 4th day symptoms started to lessen. Still do not feel well today. I did not know i could report this to anyone or I would have reported that i  was even sicker with the 2nd does of this  vaccine. It was EP7534 and i took it on 3-25-21. Symptoms much the same but i was sick for a full 5 days and lost 7 lbs during that time.
This spontaneous report as received from a pharmacist refers to 2 patients of unknown age.    On an unknown date the patients were vaccinated with ZOSTAVAX for prophylaxis.  On an unknown date the patient developed herpes zoster. The outcome of herpes zoster was unknown.; Sender's Comments:  US-009507513-1708USA001049:
Left arm numbness and aching extending down arm into finger tips, More pronounced in shoulder area and occasional tinnitus in both ears. Seeing neurologist next week
pt recv vax;8jun awakened w/ harsh cough; cough progressed & throat became tighter w/ tight chest & almost stridorous respiration;epi, aerosol alupent & dph given;poss rxn to thimerosol component
Narrative:  Pt presented to the ED on 5/12/21 with abdominal pain, nausea, and vomiting x 3 days (similar to previous episodes); work-up was negative and patient was discharged home. On 5/14/21 pt brought to ED for AMS, after EMS found her hypoglycemic at home after presumed seizure. Neurology was consulted and patient was started on Keppra daily for which she has not had any recurrent episodes of seizures. During this admission, she was also found to have acute reduced in EF on TTE (45%  to 15% in 3 months). Course of admission was c/b transaminitis. GI was consulted who thought that this could be due to ischemic liver injury 2/2 to heart failure. LFTs improved significantly with GDMT. On admission, labs were consistent with DIC with thrombocytopenia. No evidence of  thrombosis (other than on the false lumen of previously repaired aortic aneurysm), no evidence of bleeding. Patient found to have acute thrombocytopenia and DIC. Per consistent with DIC unclear and likely multifactorial. Etiology of thrombocytopenia and DIC may be from vaccine given heparin-PF4 antibody was positive. Patient was started on high dose steroids 5/16/21 for possible autoimmune thrombocytopenia with subsequent taper with improvement.
Extremely high fever, uncontrollable crying, had an ear infection within 1 week of vaccine. Never had an ear infection prior to shot. Within 2 weeks small bumps developed all over his back, back of his arms, on his shoulders, and a few places on his legs. Called the Dr. and told him about the fever and the uncontrollable crying and I was told that it was normal and to give him tylenol. I started him on tylenol but his fever wouldn't break so I switched to ibuprofen, it helped for about 2 hours but fever returned. I rotated ibuprofen and tylenol every 4-6 hrs for the following week. The fever was slightly controlled by the ibuprofen but it was a temporary fix. I started using an old trick my grandma taught me, I put a little rubbing alcohol on a rag and rubbed it on his back and legs, it worked the best at lowering the fever. This lasted for 5 days high unexplained fever and he was also sleeping 8 hours at a time, I had to wake him up to get him to eat.
There was pain when injection given. By next morning was "hot". Was given in Rt upper arm. 24 hrs later red area measured 4.5 x 4.5 cm. No lesions or pustules - local allergic reaction.
Moderna was given to a patient who was not of age to receive that vaccine.  Due to the patient's age, he should have received a Pfizer vaccine.  There were no known adverse effects at the time the vaccine was given or during observation following the vaccination.
got COVID-19 after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got COVID-19 after the second dose) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In August 2021, the patient experienced COVID-19 (got COVID-19 after the second dose). At the time of the report, COVID-19 (got COVID-19 after the second dose) outcome was unknown.            No Concomitant medications were provided by the reporter. No Treatment information was reported. This case concerns a 77-year-old female patient, with no medical history reported, who experienced non serious unexpected AESI of COVID-19 after second dose of mRNA-1273. The event occurred approximately 4 months after dose. The re-challenge is not applicable due to the nature of the event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This case concerns a 77-year-old female patient, with no medical history reported, who experienced non serious unexpected AESI of COVID-19 after second dose of mRNA-1273. The event occurred approximately 4 months after dose. The re-challenge is not applicable due to the nature of the event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
arm pain; swelling; redness; swelling; redness; sorness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling), the first episode of VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PAIN (sorness), PAIN IN EXTREMITY (arm pain) and SWELLING (swelling) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swelling), the first episode of VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PAIN (sorness). On 02-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm pain), SWELLING (swelling) and the second episode of VACCINATION SITE ERYTHEMA (redness). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at a dose of UNK dosage form, qd. On 26-Mar-2021, VACCINATION SITE SWELLING (swelling) and VACCINATION SITE PAIN (sorness) had resolved. At the time of the report, PAIN IN EXTREMITY (arm pain), SWELLING (swelling) and the last episode of VACCINATION SITE ERYTHEMA (redness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information not provided. Treatment include Asper cream.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: A follow up was received on 30-APR-2021 which contained no new information
Information has been received from a 61 year old male with no known history of allergies who on 16-MAR-2007 was vaccinated with a dose of Zostavax. There was no concomitant medication. On approximately 23-MAR-2007 (reported as a week after getting the vaccine) the patient experienced pain on his right side around the kidney area, chills and loss of appetite. A CT Scan and blood work were performed (results no reported). The patient's pain on his right side around the kidney area and chills and loss of appetite persisted. Unspecified medical attention was sought. No product quality complaint involved. Additional information has been requested. This is in follow-up to report(s) previously submitted on 4/13/2007.  Additional information was received.  On 23-MAR-2007 the physician reported that the patient experienced low back pain/chills.  The patient was evaluated further by his orthopedist.  It was also reported that symptoms felt to be due to back strain.  Additional information has been requested.
Patient reported no signs/symptoms of reaction at time of administration. Patient reports signs of adverse event starting on 11/6 with presentation back to pharmacy on 11/7/16. Left arm sight of injection. Site was red and inflamed, approximately 5 inches in diameter, with a small, hard, raised area at the sight of injection, tender to touch. Possible cellulitis. Recommended patient to urgent care/physician office visit for further evaluation and probable antibiotic therapy.
No additional adverse event reported; VAQTA experienced a temperature excursion on 29-DEC-2021. Patient was administered VAQTA after temperature excursion on 05-JAN-2022.; This spontaneous report was received from a medical assistant regarding a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant therapies, drug reactions, and allergies were not provided by the reporter.   On 29-NOV-2021, Hepatitis A Vaccine, Inactivated (VAQTA) experienced a temperature excursion. Therefore, on 05-JAN-2022, the patient was vaccinated with a improperly stored dose of Hepatitis A Vaccine, Inactivated (VAQTA) (incorrect product storage) lot number U024094, expiration date 10-MAY-2023 (dose and route of administration were not provided). No additional adverse event reported. Administered dose of vaccine experienced the temperature excursion of 35.9 degrees Fahrenheit (°F) for 0 hours 20 minutes 0 seconds. Data logger was not involved. There were no previous excursions reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2202USA007167:
Patient started getting very hoarse about 1.5 hours after vaccination. When clinic pharmacist questioned patient about condition, patient only reported hoarseness and did not report any difficulty breathing or swelling in the throat or face at that time. Pharmacist discussed what to monitor and when patient should seek immediate medical attention. Patient asked if she could take any OTC products. Pharmacist discussed OTC options with patient and re-iterated what to monitor and when patient should seek immediate medical attention.
This case was reported by a physician, via a sales representative, and described the occurrence of exacerbation of asthma symptoms in a female patient who received Advair multi dose powder inhaler for chronic obstructive pulmonary disease and asthma. Co suspect medication included influenza virus vaccine (unspecified manufacturer). Concurrent medications included Solumedrol IV, prednisone and unspecified ABX. On an unknown date, the patient started fluticasone propionate+salmeterol xinafoate (inhaled), at an unknown dosing. At an unknown time after starting fluticasone propionate+salmeterol xinafoate, the patient experienced exacerbation of asthma symptoms, cough, congestion and wheezing. This case was assessed as medically serious by manufacturer (OMIC). Treatment with fluticasone propionate+salmeterol xinafoate was continued. At the time of reporting, the outcome of the events was unknown. The physician reported that while taking fluticasone propionate+salmeterol xinafoate, the patient's asthma symptoms of coughing, congestion, and wheezing became progressively worse. The patient received influenza vaccine (unspecified manufacturer) at the end of September 2006. At an unspecified time following receipt of influenza virus vaccine on an unspecified date on or after September 2006 and on or before 17 October 2006, the patients asthma symptoms worsened significantly. The physician discontinued fluticasone propionate+salmeterol xinafoate and continued all other medications as usual, and her asthma improved. Comment exacerbation of asthma symptoms was assessed as medically serious by manufacturer.
Patient tested positive for Covid during routine surveillance.  Asymptomatic.  No other information was charted in system    Patient was not hospitalized.